Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-K for the period ended Sep 30, 2019

Filed with the SEC on Dec 20, 2019 and accepted by EDGAR at Dec 20, 2019, 22:17 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2018-10-01 to 2019-09-30$1.5mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2018-10-01 to 2019-09-30−$5.8mus-gaap:OperatingIncomeLoss
Net income12 months2018-10-01 to 2019-09-30−$6.8mus-gaap:NetIncomeLoss
Diluted EPS12 months2018-10-01 to 2019-09-30−$0.57us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2018-10-01 to 2019-09-30−$5.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2018-10-01 to 2019-09-30$58.4kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-09-30$260.7kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-09-30$301.8kus-gaap:AssetsCurrent
Total assetsAt period end2019-09-30$532.6kus-gaap:Assets
Current liabilitiesAt period end2019-09-30$1.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-09-30$1.8mus-gaap:Liabilities
Shareholders' equityAt period end2019-09-30−$1.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-19-026720. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.